|
Nature | Aptamer name | Ligand/target | Kd (nM) | Disease | Reference |
|
|
RNA aptamer | RIG1 (1-925aa) | 37.2 | Antiviral activity via modulating IFN/ production | [10] |
| AFP aptamer | AFP (fetal protein) | 33 | Hepatocellular carcinoma | [11] |
| Class III GSH aptamer 8.17 | Glutathione | 41.8 | Breast cancer (human breast adenocarcinoma cell line, MCF-7) | [12] |
| MDA aptamer M1 | MDA (4,4′-methylenedianiline) | 450 | Carcinogenic and DNA damaging agent | [13] |
| RNA aptamer | Rev peptide | 19–36 | HIV | [14] |
| RNA aptamer S66A-C6, RNA aptamer S69A-C15 | V3 loop of gp120, HIV-1RT | 406, 637 | HIV | [15] |
| Anti-gp120 aptamer chimera | Glycoprotein 120 (gp120) | na | HIV | [16] |
| Class I and Class II AChR aptamer | Acetylcholine receptor (AChR) | 2 and 12, respectively | Neuromuscular disorder | [17] |
| RNAapt TH14 | Beta-Secretase BACE1 (B1-CT) | 280 | Alzheimer’s disease | [18] |
| Anti-EGFR aptamer (E07) | Epidermal growth factor receptor | 2.4 | Breast and lung cancer | [19] |
RNA | DBL1-specific RNA aptamer | Erythrocyte membrane protein 1 (PfEMP1) | 33 inhibitory conc. | Malaria | [20] |
| 2′F RNA and 2′NH2 aptamer | Human keratinocyte growth factor | 0.0003–0.003 and 0.4 | Cancer | [21] |
| RNA aptamer (10th rounds 4°C) | L-selectin | 17 | Inflammation | [22] |
| RNA aptamer | NF-kB p50 homodimer | 5.4 2.2 | Cancer and inflammation | [23] |
| Anti-PSMA chimera | Prostate specific membrane antigen | na | Prostate cancer | [24] |
| Aptamer number 5 | T-cell factor 1 | 100 | Colon cancer | [25] |
| TTA1 | Tenascin-C | 5 | Glioblastoma, breast cancer | [26, 27] |
| RNA aptamer | TGF type III receptor | 1 | Ovarian cancer | [28] |
| Pegaptanib sodium, NX1838 | VEGF 165 (vascular endothelial growth factor 165) | 0.05 | Age related macular degeneration | [29] |
| RNA aptamer 22 | WT1 | 700 | Wilm’s tumor | [30] |
| RNA aptamer | -Catenin | 5 | Colon cancer | [31] |
| RNA aptamer G4 | K Ras-derived peptide | | Oncogenic protein | [32] |
| RNA aptamer | Amyloid beta-peptide A4 (1-40) | 29 to 48 | Alzheimer's disease | [33] |
|
| Aptamer BC15 (ssDNA aptamer) | Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) |
111.0 36.9 | Breast cancers and liver cancer | [34] |
| DNA aptamer HB5 | Her 2 (human epidermal growth factor receptor 2) | 18.9 | Her 2 positive breast cancer | [35] |
DNA | DNA aptamer | 0mpC | 20 | Food borne disease | [36] |
| DNA aptamer A and C | TTF1 (member of the NK homeodomain transcription factors) | 3.36, and 32.5 | Primary lung adenocarcinomas | [37] |
| SYL3 DNA aptamer | EpCAM (epithelial cell adhesion molecule) |
| Breast cancer (MDA-MB-231), gastric cancer (Kato III), and solid cancer | [38] |
| MUC1 DNA aptamer | MUC1 peptide (Mucin-1) | 0.135 to 33.38 | Tumor marker in neoplastic cell | [39] |
|
Peptide | Peptide aptamer | RAD 51 (pY315) | na | Leukemia | [40] |
Peptide aptamer A8 and A17 | HSP70 | na | Cancer | [41] |
Peptide aptamer E6 | HPV16 E6 oncoprotein | na | HPV positive tumor cells | [42] |
Peptide aptamer AII-7 | ErbB2 (avian erythroblastic leukemia viral oncogene homolog 2) | na | Breast cancer | [43] |
|